Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Revenue | $0 | $28.9M | $0 | $0 | $31.8M |
| Cost of revenue | $0 | $35.7M | $3.9M | $0 | $17.7M |
| Gross profit | $0 | −$6.9M | $17.7M | $0 | $14.1M |
| Gross margin | — | -23.7% | — | — | 44.4% |
| R&D | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$120.6K | −$10.3M | −$3.7M | −$2.9M | −$27.7M |
| EBITDA | $636 | −$10.1M | −$3.7M | −$2.9M | −$63.3M |
| Net income | −$120.0K | −$12.0M | $4.4M | −$1.9M | −$69.6M |
| Net margin | — | -41.5% | — | — | -218.9% |
| EPS (diluted) | -0.02 | -0.26 | 0.14 | -0.12 | -1.65 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds EMLDU.
No tracked institution reports a position in EMLDU as of their last filing.
No one on the platform has traded EMLDU yet.
| +24.16% |
| $149M |
| — |
| JMACMaxpro Capital Acquisition Corp. | $10.81 | -6.24% | $136M | — |
| LVACLAVA Medtech Acquisition Corp. | $10.43 | +0.00% | $150M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.